Bosentan

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Heinrich-Heine University, Duesseldorf

Overview

Bosentan is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 8 tracked IPF clinical trials.

Bosentan clinical trials

NCT00318175 (Phase 2)NCT00070590 (Phase 2)NCT00625469 (Phase 4)NCT01518595 (Phase 2)NCT00631475 (Phase 3)NCT00071461 (Phase 2)NCT00637065 (Phase 4)NCT00391443 (Phase 3)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about Bosentan for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.